:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autori principali:	Ma, Meiting, Chu, Zhengqi, Quan, Hongyu, Li, Hanxu, Zhou, Yuran, Han, Yanhong, Li, Kefeng, Pan, Wenjun, Wang, De-Yun, Yan, Yan, Shu, Zunpeng, Qiao, Yongkang
Natura:	Artículo científico
Lingua:	en
Pubblicazione:	Frontiers in pharmacology 2025
Accesso online:	https://pubmed.ncbi.nlm.nih.gov/40438605/
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis
di: Zezhou Shi, et al.
Pubblicazione: (2024)

Extrapleural air secondary to idiopathic pulmonary fibrosis‐related pneumomediastinum
di: Yuichi Nagata, et al.
Pubblicazione: (2024)

Familial pulmonary fibrosis: Defining inherited fibrotic lung disease in the era of clinical genetic testing
di: Joanne L. Dickinson, et al.
Pubblicazione: (2024)

HerbMet: Enhancing metabolomics data analysis for accurate identification of Chinese herbal medicines using deep learning
di: Yuyang Sha, et al.
Pubblicazione: (2024)

Not yet known side effects of pirfenidone in the treatment of idiopathic pulmonary fibrosis?
di: S. Campainha
Pubblicazione: (2016)

The soluble factor milieu in idiopathic pulmonary fibrosis dysregulates epithelial differentiation
di: Rosa K. Kortekaas, et al.
Pubblicazione: (2024)

Plausible role of INPP4A dysregulation in idiopathic pulmonary fibrosis
di: Meghana Arvind, et al.
Pubblicazione: (2024)

Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
di: Steven D. Nathan, et al.
Pubblicazione: (2024)

Transcriptomic profiling reveals the dynamics of fibrotic progression‐related gene expression into post‐coronavirus disease 2019 pulmonary fibrosis
di: Sabrina Setembre Batah, et al.
Pubblicazione: (2024)

Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
di: John A. Mackintosh, et al.
Pubblicazione: (2024)

A novel model for predicting prognosis in patients with idiopathic pulmonary fibrosis based on endoplasmic reticulum stress‐related genes
di: Bin Liu, et al.
Pubblicazione: (2024)

Clinical impact of a multidisciplinary discussion group on the diagnosis of idiopathic pulmonary fibrosis in Colombia
di: MAURICIO GONZÁLEZ-GARCÍA
Pubblicazione: (2022)

Using evidence in clinical practice: A dream coming true in idiopathic pulmonary fibrosis
di: G. Sgalla
Pubblicazione: (2017)

Unveiling the role of copper metabolism and STEAP2 in idiopathic pulmonary fibrosis molecular landscape
di: Yajun Wang, et al.
Pubblicazione: (2024)

Lichen planus pigmentosus‐like reaction to pirfenidone in a patient with idiopathic pulmonary fibrosis
di: Marijana Vičić, et al.
Pubblicazione: (2024)

The mitigating effect of para‐hydroxycinnamic acid in bleomycin‐induced pulmonary fibrosis in mice through targeting oxidative, inflammatory and fibrotic pathways
di: Zeena A. Hussein, et al.
Pubblicazione: (2024)

The potential lipid biomarker 5‐HETE for acute exacerbation identified by metabolomics in patients with idiopathic pulmonary fibrosis
di: Yichao Zhao, et al.
Pubblicazione: (2024)

Ginsenoside Rh4 alleviates idiopathic pulmonary fibrosis by enhancing the CXCL9–CXCR3 axis
di: Lei Yao, et al.
Pubblicazione: (2024)

Cordyceps sinensis ameliorates idiopathic pulmonary fibrosis in mice via inhibiting mitochondrion‐mediated oxidative stress
di: Ying Zhang, et al.
Pubblicazione: (2024)

Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice
di: Lu Bai, et al.
Pubblicazione: (2024)

Metformin enhanced the effect of pirfenidone on pulmonary fibrosis in mice
di: Nana Liu, et al.
Pubblicazione: (2024)

Evaluating the robustness of deep learning models trained to diagnose idiopathic pulmonary fibrosis using a retrospective study
di: Wenxi Yu, et al.
Pubblicazione: (2025)

Engineering the immune and fibrotic response in VML
di: Dallas E. Altamirano, et al.
Pubblicazione: (2025)

Distinct lung functional, histological and cell senescence signatures in the single and repetitive bleomycin mouse models of idiopathic pulmonary fibrosis
di: Jamal Bousamaki, et al.
Pubblicazione: (2025)

Steroid therapy in acute exacerbation of fibrotic interstitial lung disease
di: Kavya Koshy, et al.
Pubblicazione: (2024)

Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi‐centre registry cohort
di: Veronica Marcoux, et al.
Pubblicazione: (2024)

Genome mining of nonenzymatic ortho-quinone methide-based pseudonatural products from ascidian-derived fungus Diaporthe sp.SYSU-MS4722.
di: Ren, Shuya, et al.
Pubblicazione: (2025)

Data for paper titled "DDIT4 promotes aberrant differentiation of alveolar epithelial cells by accelerating impaired autophagy in the idiopathic pulmonary fibrosis"
di: Park, Jaehyun
Pubblicazione: (2025)

Advances in management of pulmonary fibrosis
di: Julia A. Lachowicz, et al.
Pubblicazione: (2025)

Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence
di: C. Robalo-Cordeiro
Pubblicazione: (2017)

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients
di: Dávid Nagy, et al.
Pubblicazione: (2025)

Dual‐Mode Quartz‐Enhanced Spectroscopy Enabled by Mixed Heterodyne Demodulation for Frequency‐Mismatch‐Free Gas Sensing
di: Hanxu Ma, et al.
Pubblicazione: (2025)

Multiple pulmonary nodules with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and minute pulmonary meningothelial‐like nodules
di: Tsuyoshi Sasada, et al.
Pubblicazione: (2024)

Advances in common in vitro cellular models of pulmonary fibrosis
di: Die Li, et al.
Pubblicazione: (2024)

Pathological predictor of progressive pulmonary fibrosis
di: Ae Ri Ahn, et al.
Pubblicazione: (2025)

A High‐Sensitivity Light‐Induced Thermoelastic Spectroscopy Sensor Based on Dual‐Path Synergistic Coupling Method
di: Hanxu Ma, et al.
Pubblicazione: (2026)

A digital therapy targeting anxiety in pulmonary fibrosis: A decentralized randomized controlled trial
di: Joshua J. Solomon, et al.
Pubblicazione: (2024)

Histone methyltransferase KMT2A promotes pulmonary fibrogenesis via targeting pro‐fibrotic factor PU.1 in fibroblasts
di: Wenting Lyu, et al.
Pubblicazione: (2025)

Leveraging Optimal Transport for Distributed Two-Sample Testing: An Integrated Transportation Distance-based Framework
di: Lin, Zhengqi, et al.
Pubblicazione: (2025)

Current insights into pathogenesis and anti‐inflammatory treatment strategies for severe alcohol‐associated hepatitis: focus on neutrophil‐targeted therapies
di: Ryosuke Kasuga, et al.
Pubblicazione: (2025)